ABOUT
JERRY POMMER
Jerry Pommer, MSc, PAS, DACAWS
Jerry Pommer founded OVIS LLC in 1991 and is currently the Owner/Manager of OVIS. He has been instrumental in implementing high quality animal care and use programs that have maintained United State Department of Agriculture (USDA), National Institute of Health (NIH), and Food and Drug Agencies (FDA) regulatory compliance, and Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) accreditation. He has overseen regulatory compliance and quality assurance regarding the purification of human polyclonal antibodies from transchromosomal (Tc) bovine plasma. He is responsible for animal and drug filings with FDA, Center for Veterinary Medicine (CVM) and Center for Biological Evaluation and Research (CBER). He continues to work with various national committees and discussion groups that focus on animal biotechnology and actively participates in the discussions for establishing a federal regulatory framework for this technology.
Jerry received his Masters of Science Degree (MSc) in Veterinary/Microbiology Sciences from North Dakota State University and received his Bachelor of Science Degree (BS) in Biology/Microbiology from South Dakota State University. He is currently a certified Professional Animal Scientist (PAS) with the Federation of Animal Science Societies (FASS) and board certified as a Diplomat with the American College of Animal Sciences - Animal Welfare Science Discipline (DACAWS).
Positions and Honors
Vice President/Chief Compliance Officer of Regulatory Compliance
Oversee animal and manufacturing regulatory compliance and quality assurance in a GE cattle production system for developing human polyclonal antibodies used for biopharmaceutical purposes. SAB Biotherapeutics Inc., 4401 S. Technology Drive, Sioux Falls, South Dakota, 57106. Jul. 2014 – Mar. 2022.
Owner/Manager
Development and maintaining of a specific pathogen free sheep flock for biomedical research and antiserum production in the areas of agriculture and biomedical sciences. OVIS LLC, 47825 279th Street, Canton, South Dakota 57013. Mar. 1991 – Present.
Director of Large Animal Regulatory Compliance
Oversee animal regulatory compliance, animal welfare, and quality assurance in a GE cattle production system for developing human polyclonal antibodies used for biopharmaceutical purposes. Sanford Applied Biosciences LLC, 4401 S. Technology Drive, Sioux Falls, South Dakota, 57106. Jan. 2013 – Jun 2014.
Executive Director of Animal Regulatory Compliance and Quality Assurance
Oversee animal regulatory compliance, animal welfare and quality assurance in the animal production system for developing human polyclonal antibodies used for biopharmaceutical purposes. Hematech Inc., 4401 S. Technology Drive, Sioux Falls, South Dakota, 57106. Nov. 2003 – Dec. 2012.
Director of Quality Systems
Establish procedures for maintaining standards of animal welfare and quality assurance in the daily operations at the Genetic Advancement Center for the development of transgenic animals that are used for human biopharmaceutical purposes. Trans Ova Genetics LLC, 2938 380th Street, Sioux Center, IA 51250. Aug. 1997- Nov. 2003.
Project Leader
Development of animal model (sheep) and immunoassays for the detection of viral antigen in vaccine production. Grand Laboratories, Inc., Larchwood, Iowa 51241. Aug. 1992 – Feb. 1996.
Diagnostic Laboratory Manager
Manage the daily functions of a diagnostic laboratory for autogenous vaccine production. Grand Laboratories, Inc., Larchwood, Iowa 51241. Apr. 1989 – Aug. 1992.
Microbiologist II
Supervise technical support staff in maintenance and function of the diagnostic virology laboratory. North Dakota State University, Department of Veterinary Science, Fargo, North Dakota 58105. Aug. 1981 – Feb. 1989.
Medical Technologist
Supervise support staff in maintenance and function of diagnostic laboratory. North Platte Experiment Station, Veterinary Science Department, North Platte, Nebraska 69101. Sept. 1980 – Aug. 1981.
Laboratory Technician
Worked part-time as a laboratory technician while obtaining B.S. degree as a full-time student. South Dakota State University, Veterinary Science Animal Disease Research and Diagnostic Laboratory, Brookings, South Dakota 57007. Aug. 1977 – Aug. 1980.
Contribution to Science
PUBLICATIONS:
Isolation of Adenovirus from Lambs with an Upper Respiratory Syndrome.
Journal of Veterinary Diagnostic Investigation, May, 1991.
Exploring the Regulatory and Commercialization Issues related to Genetically Engineered Animals.
The Pew Initiative on Food and Biotechnology, Dec., 2005
The Role of Transgenic Livestock in the Treatment of Human Disease.
CAST No., 35, May 2007.
Viral Risk Assessment of Harvested Bovine Oocytes from Abattoir Origin.
Reproduction, Fertility, and Development Journal; Vol. 20, Issue 1, 2008.
Commercializing Genetically Engineered Animal Biomedical Products.
Reproduction, Fertility and Development Journal; Vol. 20, Issue 1, 2008.
Research Note: Sheep Antiserum as an Antibody Supplement in Newborn Lambs.
Sheep and Goat Research Journal; Vol. 25, 2010.
Commercializing Genetically Engineered Cloned Cattle.
Principles of Cloning, Chapter 27, Elsevier Pub. Inc, 2014.
CONFERENCES:
Invited Speaker: “Production of Human Polyclonal Antibodies in Transchromosomic Cattle”, Academy of Veterinary Science, Denver, CO. December 3, 2004.
Speaker: “Production of Genetically Engineered Cattle Lacking Prion Protein”, Conference on Transmissible Spongiform Encephalopathy Diseases, Boston, MA. February 15, 2007.
Invited Speaker: “Genetically Engineered and Cloned Animals Used in Agricultural and Biomedical Sciences”, Federation of Animal Science Society, Denver, CO. July 17, 2007.
Invited Speaker: “Genetically Engineered Cattle for Human Biomedical Applications”, Sertoma Club, Sioux Falls, SD. Dec. 16, 2008.
Speaker: “Genetically Engineered Animal Stewardship Program”, BIO-Livestock Biotech Summit, Sioux Falls, SD. Sept. 21, 2010.
Invited Speaker: “Increasing Transgenic Protein Production”, Transgenic Animal Conference, Lake Tahoe, CA. Aug. 11, 2011.
Speaker: “Genetically Engineered Animal Stewardship Program”, BIO-Livestock Biotech Summit, Kansas City, MO. Sept. 19, 2012.
Speaker: "USA Regulatory Pathway for Human Polyclonal Antibody Therapies Derived from Transchromosomal Bovine" TECBIO, Fortaleza, Brazil, July, 26, 2017.
COMMITTEES:
Stakeholder Forum Member: Issues in the Regulation of Genetically Engineered Plants and Animals, Pew Initiative on Food and Biotechnology, 2001-2003.
Stakeholder Participant: Exploring the Moral and Ethical Aspects of Genetically Engineered and Cloned Animals, Pew Initiative on Food and Biotechnology, January 24-26, 2005.
Stakeholder Participant: Exploring the Regulatory and Commercialization Issues Related to Genetically Engineered Animals, Pew Initiative on Food and Biotechnology, May 21-24, 2005.
Co- Chairperson: BIO-Livestock Biotech Summit, Sioux Falls, SD. Sept 19-21, 2010.
Co- Chairperson: BIO-Livestock Biotech Summit, Kansas, MO. Sept 19-21, 2012.
Co- Chairperson: BIO-Livestock Biotech Summit, Sioux Falls, SD. Sept 17-19, 2014.
